Ben Inker (gmo) explains how valuation should be a key driver of how an investor's asset allocation looks at a given life stage.
The Biggest Shortcoming With Glide-Paths In Target-Date Funds
Ben Inker (gmo) explains how valuation should be a key driver of how an investor's asset allocation looks at a given life stage.
